NCT03716336

Brief Summary

A total of 42 premenopausal women diagnosed clinically as having insulin resistance. Their ages ranged from 35 to 45 years old; their body mass index was \>30 kg/m2 and They were obese women complained of insulin resistance and non diabetic or cardiovascular disease, were randomly assigned to group A participated in aerobic \& resistive exercise program, and group B participated in aerobic exercise and followed prescribed diet restriction program. Both of the groups (A\&B) followed the treatment program 3 times per weeks for 8 weeks. Assessment of the fasting glucose, fasting insulin, and HOMA test of insulin resistance were measured for all subjects in both groups (A and B) was carried out before and after the end of the treatment program

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 23, 2018

Completed
Last Updated

October 19, 2020

Status Verified

October 1, 2020

Enrollment Period

6 months

First QC Date

October 21, 2018

Last Update Submit

October 13, 2020

Conditions

Keywords

resistive exercisesaerobic exercisesdietinsulin resistancepremenopausal

Outcome Measures

Primary Outcomes (1)

  • HOMA test of insulin

    A sample of 5ml of venous blood sample was drawn from the ante cubital vein after 10 hours fasting from all women in the two groups (A, B) for measurement of fasting blood glucose, fasting blood insulin and detection of insulin resistance (by HOMA-IR)

    8 weeks

Secondary Outcomes (2)

  • fasting blood insulin level

    8 weeks

  • fasting blood glucose level

    8 weeks

Study Arms (2)

aerobic exercise

OTHER

walking on treadmill

Other: Resistance exerciseOther: Aerobic exerciseDietary Supplement: diet restriction

resistive exercise

OTHER

Resistance exercise were performed for all participants in group (A) included 9 exercise for big muscles of upper limbs

Other: Resistance exerciseOther: Aerobic exerciseDietary Supplement: diet restriction

Interventions

Resistance exercise were performed for all participants in group (A) only included 9 exercise for big muscles of upper limbs (shoulder flexors muscles, shoulder extensors and shoulder abductors), lower limbs (hip flexors, hip extensors and knee flexors and knee extensors) and abdominal muscle using moderate work load (60 - 75% of IRM) 1set of 10 repetitions, progressing to 2 sets of 10 repetitions after four weeks for 20 minutes

aerobic exerciseresistive exercise

aerobic exercise were performed on treadmill. For 20 minutes. All patients in both groups (A,B) had attended the program of a resistance exercises and followed by aerobic exercise for 8 weeks in form of 20 minutes walking on the treadmill without inclination.

Also known as: exercise
aerobic exerciseresistive exercise
diet restrictionDIETARY_SUPPLEMENT

All participants in both groups (A,B) were instructed to follow a moderate restricted diet limited to (1800-2000) kcal/ day under supervision of a certified dietician. The diet contained: Protein and fibers: 20% carbohydrate: 50-60%, fat: low 20%.

aerobic exerciseresistive exercise

Eligibility Criteria

Age35 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Their age ranged from 35 - 45years.
  • their body mass (BMI) were\>30kg/m2.

You may not qualify if:

  • Patients having diabetic or cardiovascular disease.
  • Patients with life threatening disorders as renal failure and myocardial infarction
  • Patients with active malignancy.
  • patients with severe hemorrhage
  • hyperthyroidism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of physical therapy- Cairo University

Giza, Dokki, 12613, Egypt

Location

MeSH Terms

Conditions

Metabolic SyndromeInsulin Resistance

Interventions

Resistance TrainingExercise

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • ghada eb elrefaye, professor

    institutional review board of the Faculty of physical therapy, Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participants were assigned randomly used sealed envelope into two groups (A\&B) equally in number.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: were randomly assigned to group A participated in aerobic and resistive exercise program, and group B participated in aerobic exercise and followed prescribed diet restriction program. Both of the groups (A\&B) followed the treatment program 3 times per weeks for 8 weeks. Assessment of the fasting glucose, fasting insulin, and HOMA test of insulin resistance were measured for all subjects in both groups (A and B) was carried out before and after the end of the treatment program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor of physical therapy for women's health

Study Record Dates

First Submitted

October 21, 2018

First Posted

October 23, 2018

Study Start

November 1, 2017

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

October 19, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations